Urinary tract infection by a rare pathogen Cedecea neteri in a pregnant female with Polyhydramnios: rare case report from UAE
| Autor: | Satyam A Parmar, Debadatta Panigrahi, Talat Masroor, Hafiz Imtiaz Ahmad |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Adult
Polyhydramnios 0301 basic medicine medicine.medical_specialty medicine.drug_class Urinary system Cedecea neteri 030106 microbiology Antibiotics United Arab Emirates Case Report Infectious and parasitic diseases RC109-216 03 medical and health sciences 0302 clinical medicine Antibiotic resistance Medical microbiology Enterobacteriaceae Pregnancy Humans Medicine 030212 general & internal medicine Intensive care medicine Pathogen Rare pathogen Urinary tract infection biology business.industry Enterobacteriaceae Infections Prognosis biology.organism_classification medicine.disease Anti-Bacterial Agents Multi-drug resistance Infectious Diseases Parasitology Urinary Tract Infections Female Pregnant Women business Cedecea |
| Zdroj: | BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021) BMC Infectious Diseases |
| ISSN: | 1471-2334 |
| Popis: | Background Cedecea neteri is a gram-negative, oxidase-negative bacillus, a rare pathogen. Few reports are emerging globally about its antimicrobial resistance pattern especially in immunocompromised individuals with comorbidities. Case presentation In this paper, we report the first case of C. neteri causing urinary tract infection in a pregnant woman at a specialty care hospital in the Northern Emirates of Ras al Khaimah, UAE. Discussion and conclusion C. neteri is a rare and unusual pathogen, unlike routine gram-negative urinary tract pathogens from the family of Enterobacteriaceae and therefore may be missed or misidentified by routine laboratories using conventional microbiology identification techniques. Hence, Cedecea infections may be under-reported. Physicians and microbiology technicians must be aware of such a rare pathogen, as most of the isolates are multi-drug-resistant and require combined antibiotic treatment with beta-lactamase inhibitors and hence pose a treatment challenge especially in immunocompromised patients with comorbidities. In recent years, it has been reported as an emerging opportunistic pathogen. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |